|
ateganosine Clinical Trials
1 actively recruiting trial across 1 location
Also known as: THIO, 6-thio-dG, 6-thio-2'-deoxyguanosine
Pipeline
Early 1: 1
Top Sponsors
- University of Texas Southwestern Medical Center1
Indications
- Liver Disease1
- Resectable Hepatocellular Carcinoma1
- Liver Cancer1
- Cancer1
Dallas, Texas1 trial
THIO and Cadonilimab in Resectable Hepatocellular Carcinoma
University of Texas Southwestern Medical Center
Early 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.